Vir Bio (VIR) reveals 24-week post-end-of-treatment data from a mid-stage trial for its Hep B therapy developed with Xencor ...

Discover an awarding winning abstract from EASL 2025 that has called for more person-centred hepatitis screening. Learn more.

An aerial view of downtown Los Angeles. Los Angeles County last year recorded a total of 165 cases of hepatitis A, triple the number seen in 2023, and the highest in the county in at least a ...

Discover a recent study presented at EASL 2025 that explored the impact of opt-out testing for blood-borne viruses in ...

Despite the standard immunoprophylaxis, a significant portion of infants born to highly viremic mothers remain infected with hepatitis B virus (HBV). Emerging data suggest that antiviral therapy ...

Hepatitis A is a highly contagious disease that affects the liver. It’s most often spread when people eat food or drink water that’s been contaminated by the virus, and contamination usually ...

Researchers in India evaluated 1387 adults with asymptomatic hepatitis B virus (HBV) infection to determine the correlation between liver-enzyme elevations and histologic disease. Presumably ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Hepatitis D is a type of viral hepatitis that affects around 48 million people worldwide. It is less common than other types of hepatitis that you might be more familiar with. Hepatitis D is thought ...